InvestorsHub Logo
Followers 3
Posts 277
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Sunday, 05/14/2023 5:56:35 PM

Sunday, May 14, 2023 5:56:35 PM

Post# of 3283
New Rolvedon sales forecast. "Spectrum Pharmaceuticals' five analysts are now forecasting revenues of US$67m in 2023. Before this consensus update, the analysts had been forecasting revenues of US$55m". But after merger with ASRT who cares.
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sppi/spectrum-pharmaceuticals/news/analysts-just-made-a-huge-upgrade-to-their-spectrum-pharmace